2 The concentration-dependent activation and desensitization of the ion currents evoked by the agonists yield the potency order: mCPBG > 5-HTQ % 5-HT > > tryptamine > dopamine, and the efficacy order: 5-HT mCPBG 5-HTQ> > dopamine tryptamine. Thus, 5-HT, 5-HTQ and mCPBG are full agonists, whereas dopamine and tryptamine are partial agonists at the 5-HT3 receptor. 3 Full and partial agonists cause complete cross-desensitization and activate single channels with similar conductances and open lifetimes. This shows that full and partial agonists act on the same population of 5-HT3 receptors. 4 The time course of recovery from desensitization depends on the agonist used. Recovery from partial agonist-induced desensitization is single exponential, whereas the desensitization induced by full agonists recovers with sigmoid kinetics, suggesting at least 3 steps between 4 states. 5 During the process of recovery from cross-desensitization, the full agonists activate a larger fraction of the 5-HT3 receptors than the partial agonists, irrespective of the agonist used to induce desensitization. 6 It is concluded that full and partial agonists induce distinct desensitized states and, during recovery from desensitization, recognize distinct conformations of unoccupied 5-HT3 receptors. This conformational selection is likely to account for the different efficacies of full and partial 5-HT3, receptor agonists.
Introduction
The 5-HT3 receptor is a ligand-gated ion channel with properties similar to nicotinic acetylcholine (nACh) receptors. These properties include molecular structure (Maricq et al., 1991) and agonist-induced activation and desensitization of ion current (Neijt et al., 1989; Eisele et al., 1993; Yakel et al., 1993) , which is mediated by cation channels (Yakel et al., 1990; Yang, 1990) . In mouse NIE-115 neuroblastoma cells, 5-HT3 receptors have been investigated in detail. From these cells the functional characteristics of the 5-HT3 receptor-mediated macroscopic whole-cell ion current (Neijt et al., 1986; Lambert et al., 1989) and microscopic single channel events Hooft & Vijverberg, 1995) , as well as the ligand-binding profile of the recognition site (Hoyer & Neijt, 1988; Lummis et al., 1990 ) and the primary sequence of the cloned 5-HT3 receptor subunit (5-HT3R-A) and a splice variant (5-HT3R-A,) have been reported (Hope et al., 1993) .
Application of the agonist 5-HT to whole-cell voltage clamped NlE-115 cells induces a rapidly activating cation current, which desensitizes in the continuous presence of the agonist (Neijt et al., 1989) . Similar transient ion currents are evoked by the application of other 5-HT3 receptor agonists, e.g., dopamine (Neijt et al., 1986) , 2-methyl-5-HT and metachlorophenylbiguanide (mCPBG) (Sepulveda et al., 1991) . Dopamine acts as a low-affinity, partial agonist on the 5-HT3 receptor, with an efficacy of approximately 40% of that of 5-HT, as measured by the amplitude ratio of the maximum in-1 Author for correspondence.
ward currents induced by the two agonists (Neijt et al., 1986) . The selective 5-HT3 receptor agonist, 2-methyl-5-HT, which binds to 5-HT3 receptors in N1E-115 cells with similar affinity to 5-HT (Hoyer & Neijt, 1988) , is also a partial agonist with an efficacy of 63% on 5-HT3R-A and of only 9% on 5-HT3R-As homopentameric receptors expressed in Xenopus oocytes (Downie et al., 1994) . The agonists mCPBG and 5-HTQ are high-affinity receptor ligands and the former has been shown to act as a full 5-HT3 receptor agonist in NIE-115 cells. The apparent affinities of mCPBG and 5-HTQ obtained from radioligand binding experiments are much higher than those obtained from functional 5-HT3 receptor assays, in which these agonists are nearly equipotent to 5-HT (Richardson et al., 1985; Glennon et al., 1991; Sepilveda et al., 1991; Boess et al., 1992; Lummis et al., 1993) .
The mechanisms that determine the efficacy of agonists at ligand-gated ion channels are still obscure. Two general principles proposed to account for differences in agonist efficacy are conformational induction and conformational selection (Kenakin, 1995) . For some ligand-gated ion channels effects of different agonists have been compared at the single channel level. Unitary events induced by a range of nACh receptor agonists appear to have the same single channel conductance (Gardner et al., 1984) , but different open and closed channel lifetimes (Colquhoun & Sakmann, 1985; Papke et al., 1988) . For GABAA receptors, it has been reported that different agonists preferentially activate distinct subconductance states of the ligand-gated Cl-channel (Mistry & Hablitz, 1990) . Both mechanisms may reflect differences in agonist efficacy resulting from a mechanism involving conformational induction. In NIE-115 cells, 5-HT3 receptor-gated single channel events with 4 conductance states have been characterized in the presence of 5-HT van Hooft & Vijverberg, 1995) . In order to demonstrate differences in 5-HT3 receptor agonist efficacy, we have compared the concentrationdependent activation and desensitization of ion currents evoked by full and partial agonists in whole-cell voltage clamp experiments. To examine the mechanisms underlying these differences, single channel events induced by full and partial agonists in cell-attached patches of N1E-115 neuroblastoma cells have been compared and additional kinetic experiments have been performed.
Methods

Cell culture
Mouse neuroblastoma cells of the clone N1E-115 (Amano et al., 1972) were grown under conditions identical to those described before by Neijt et al. (1989) . Differentiation of subcultures of passage numbers 32-42 was initiated on day 2 in subculture by the addition of 1 mM dibutyryl-cyclic-AMP and 1 mM 3-isobutyl-1-methylxanthine to the culture medium. This medium was refreshed each 2-3 days. Cells were used for experiments on day 7-14 after subculture.
Whole-cell voltage clamp experiments
Membrane currents were recorded by a suction pipette technique for whole-cell voltage clamp as described by Lee et al. (1978) and Neijt et al. (1989) Single channel patch clamp experiments 5-HT3 receptor-gated single channels were recorded in the cellattached patch configuration with an EPC-7 patch clamp circuit (List-Electronic, Darmstadt, Germany) as described previously (van Hooft & Vijverberg, 1995) . Borosilicate glass pipettes (10-20 MQ) filled with agonist-containing external solution were positioned against the cell membrane. From each patch, 50 s of agonist-induced single channel activity was recorded immediately after gigaseal formation. The pipette solution contained (in mM): NaCl 180, HEPES 10, CaCl2 1.8, MgCl2 0.8. (pH adjusted to 7.3 with approximately 2.5 mM NaOH).
Whole-cell and single channel ion currents were low-pass filtered (8-pole Bessel filter, corner frequency 600 Hz), digitized (12 bits, 1024 points/record) and stored on magnetic disk for off-line analysis. All experiments were performed at room temperature (20 -24°C).
Drugs
Aliquots of frozen stock solutions of 5-hydroxytryptamine creatinine sulphate (Sigma, St. Louis, U.S.A.), tryptamine hydrochloride (Aldrich, Bornem, Belgium), dopamine hydrochloride, 3-tropanyl-3,5-dichlorobenzoate (MDL 72222), N,N,N-trimethyl-5-hydroxytryptamine iodide (5-HTQ) and meta-chlorophenyl-biguanide hydrochloride (Research Biochemicals Inc., Natick, U.S.A.) were thawed prior to the experiments and diluted in external solution.
Curve fitting
Parameter estimates of concentration-effect curves were obtained by fitting the function:
The sigmoid onset of recovery from desensitization induced by some of the agonists suggests a multistep mechanism. Since the agonist is rapidly removed during washing the simplest irreversible process with an unknown number of steps, each with identical rate constant a was assumed:
where D denotes the desensitized receptor states and R denotes the state of the receptor that has recovered from desensitization. For n steps, i.e., n + 1 states, the rate of arrival in R as a function of time, given that the system starts in the leftmost state D at t = 0, can be derived and integrated to yield:
in which r = 1/ac. Note that for n = 1 this is a monoexponential function. All functions were fitted using a Levenberg-Marquardt non-linear least-squares algorithm (Marquardt, 1963 (Marquardt, 1963) , and evaluated by testing with the x2 goodness-of-fit test (Bendat & Piersol, 1971 
Results
Potencies and efficacies for 5-HT3 receptor activation
The superfusion of whole-cell voltage clamped Ni E-1 15 cells with 5-HT, 5-HTQ, mCPBG, dopamine and tryptamine evoked transient inward currents (Figure la ). These responses were completely and reversibly blocked in the presence of 50 nm of the selective 5-HT3 receptor antagonist, MDL 72222, indicating that all agonist-evoked inward currents were mediated by 5-HT3 receptors (not shown). Figure la shows that the inward currents, evoked by concentrations of the various agonists which induced a nearly maximum inward current (see below), had different kinetics and amplitudes. The time constants of inward current decay were 4.2 + 1.0 s (n = 16) in the presence of 10 tuM 5-HT, and 5.8 + 1.3 s (n = 10) and 3.9 + 1.5 s (n= 5) in the presence of 10 yM 5-HTQ and 10 yM mCPBG respectively. In addition, time constants of decay of 11.2 + 5.1 s (n = 8) for 1 mM dopamine-and of 22.7 + 6.0 s (n = 6) for 100 IM tryptamine-induced inward current were obtained. Since it has been shown previously that the rate of decay of the 5-HT-induced inward current, i.e., the rate of onset of desensitization, saturates at high agonist concentrations (Neijt et al., 1989) , the different kinetics reflect differences in the intrinsic ability of the various agonists to induce desensitization of the 5-HT3 receptor-mediated ion current. Figure lb shows the concentration-effect curves of the five agonists. The data show that 5-HT and 5-HTQ were equipotent 5-HT3 receptor agonists, and that mCPBG was slightly more potent. The agonists 5-HT, 5-HTQ and mCPBG have high efficacies in evoking 5-HT3 receptor-mediated inward current, as the fitted Emax values of the concentration-effect curves of 5-HTQ and mCPBG amounted to 80.6 + 1.9% (n = 4) and 87.3+2.4% (n=3) of that of 5-HT, respectively. Dopamine and tryptamine were much less potent than the other agonists investigated and also appear to be partial agonists of the 5-HT3 receptor with efficacies of 36.1 + 7.5% (n = 4) and 33.0 + 3.8% (n = 4), respectively. Hill coefficients of the desensitization curves were higher than those of the activation curves (Table 1 ). Figure 2 and Table 1 show that the potency orders for activation and desensitization were identical and that full as well as partial agonists were able to desensitize completely the 5-HT3 receptor-mediated inward current. For the partial agonist, dopamine, a similar concentration-dependent, complete desensitization of the 5-HT3 receptor-mediated membrane depolarizing responses in NiE-115 cells has been demonstrated before . from single channel I-V curves (Figure 4) , were 27.8+ 1.7 pS (n=4), 27.6+2.1 pS (n=5) and 27.2+2.4 pS (n= 3), respectively. In addition, for single channel events evoked by 5-HT, dopamine and mCPBG, the probability of occurrence of the 27 pS level was 68.4+9.9% (n=3) 
Dynamic equilibria between receptor states
The similarity in open channel parameters suggests that the large differences in efficacy between full and partial 5-HT3 receptor agonists might be due to differences in dynamic equilibria between receptor states, e.g., resting and desensitized states. As the kinetics of most of the various steps of receptor activation and desensitization are either rapid or complex to study, we chose to investigate the recovery from desensitization. This is a relatively simple situation in which complete desensitization is induced and, subsequently, the agonist is washed off rapidly. The fraction of the 5-HT3 receptors available for activation can be measured from the amplitude of the inward current evoked by superfusion of the cell with a near maximum-effective concentration of agonist. By varying the period of washing the kinetics of recovery from desensitization can be obtained (Neijt et al., 1989) . Figure 5a shows the time course of recovery from desensitization of the 1 mm dopamine-and 100 tM tryptamine-induced inward currents. Both curves are best fitted by Eqn. (n = 3). This confirms our previous finding with 5-HT (Neijt et al., 1989 ) that the time course of recovery from desensitization is independent of the concentration of agonist used to induce desensitization. In order to exclude the possibility that, during the recovery from desensitization, reassociation of the agonist contributes to the sigmoid time course, 10 mM of the rapidly acting competitive antagonist TEA (Kooyman et al., 1993b) was applied during washing off the agonist. The time constant and exponent of recovery from 5-HT-induced desensitization in the presence of 10 mM TEA were 9.4+ 1.4 s and 2.8 +0.2 (n = 3). These values are similar to the values obtained without TEA indicating that reassociation of the agonist does not contribute to the sigmoid time course of recovery from desensitization. As outlined in scheme [2], the results suggest that recovery from partial agonist-induced desensitization required at least 1 step between 2 states, whereas recovery from full agonist-induced desensitization required at least 3 steps between 4 states.
Thus far, the recovery from desensitization was monitored with the same agonist as used to induce desensitization. In order to investigate whether recovery from desensitization also depends on the agonist used to monitor the fraction of receptors that has returned to the resting state, recovery from cross-desensitization was examined. For these experiments complete desensitization was induced by one agonist and the recovery was measured with another agonist (Figure 6a ). Recovery from tryptamine-induced desensitization after a fixed recovery period of 10 s was monitored using 5-HT, mCPBG, dopamine and tryptamine (Figure 6b ). Despite the fact that the agonists were applied at exactly the same stage of recovery from tryptamine-induced desensitization, the apparent recovery of the full agonist-evoked responses was greater than that of the partial agonist-induced responses. This implies that the full agonists activate a larger fraction of the 5-HT3 receptors which have returned to the resting state after 10 s of recovery from tryptamine-induced desensitization. (Figure 6d) was fitted by Eqn.
[3] with a time constant of 13.7 + 2.0 s and an exponent of 0.7 + 0.2 (n = 3). Similar experiments were performed in which desensitization was induced with 10 yM 5-HT and recovery was measured with 100 pM tryptamine (not shown). These experiments yielded a time constant of recovery of 13.8 + 0.7 s and an exponent of 3.1 + 0.4 (n = 3). Comparison of the curves fitted to the recovery from desensitization ( Figure 5 ) with those fitted to the recovery from cross-desensitization shows that the values of the exponent, i.e. the number of steps between the desensitized and resting states, depends on the agonist used to induce desensitization. and mCPBG (IC50 = 2 nM; Sepulveda et al., 1991) Figure 5a ). 1992). Agonist effects also seem to involve aromatic and cationic interactions with the 5-HT3 receptor as demonstrated by the distinct effects of the quarternary ammonium ion TEA, which resembles the cationic moiety of the 5-HTQ molecule and competitively blocks 5-HT3 receptor-mediated inward current (Kooyman et al., 1993b) , and 5-hydroxyindole, the aromatic moiety of 5-HT, which prevents desensitization of the inward current (Kooyman et al., 1993a; . The present results show that the quaternary agonist, 5-HTQ and 5-HT have identical potencies and efficacies, indicating that the small change of the cationic moiety of 5-HT has little effect on agonist interaction. Conversely, the potency and efficacy of tryptamine, which is identical to 5-HT except for the absence of the hydroxyl residue in the aromatic moiety, are greatly reduced as compared to 5-HT. This indicates that changes of the aromatic moiety of the agonist greatly affect 5-HT3 receptor agonist potency and efficacy. The large differences in efficacy between the full agonists 5-HT, 5-HTQ and mCPBG and the partial agonists dopamine and tryptamine cannot be accounted for by various plausible mechanisms: (1) Open time distribution and conductance of single channel events induced by the partial agonist dopamine are very similar to those induced by the full agonists 5-HT and mCPBG (Figure 4) . With a more detailed analysis of the single channel kinetics, as performed previously for nACh receptorgated ion channels (Colquhoun & Sakmann, 1985) , subtle differences in full and partial agonist-induced single channel kinetics might be revealed. At present however, such an analysis of 5-HT3 receptor-mediated single channels is hampered by the low event frequency (Figure 4) and desensitization of the channels in the cell-attached patch configuration. Nonetheless, within the limits of the present experimental accuracy, the 60% difference in efficacy of 5-HT3 receptor agonists cannot be explained by differences in channel conductance and/or burst length. The only single channel parameter that relates to the different effects of the agonists is the probability of channel opening (PO), as reflected by the different event frequencies observed (Figure 4) . (2) Although the partial agonist-induced currents activate more slowly than the full agonist-induced currents, activation kinetics are always much more rapid than desensitization kinetics (Figure la) . Any underestimation of the peak amplitudes of the more rapid, full agonist-induced currents would result in a yet greater difference in efficacy between full and partial agonists. (3) The possibility that partial agonists act on a subset of 5-HT3 receptors can also be excluded, since the partial agonists cause complete desensitization of the full agonist-induced currents (Figure 3 ). In this respect the expression of both 5-HT3R-A and 5-HT3R-A, mRNA's in N1E-1 15 cells (Hope et al., 1993) is of particular interest. Previously we have found that, in the differentiated NIE-115 cells, the efficacy of 2-methyl-5-HT is approximately 75% of that of 5-HT (Kooyman et al., 1993a) , suggesting the predominant expression of the 5-HT3R-A subunit (Downie et al., 1994) . Moreover, all concentration-effect curves presented (Figures lb and 2 ) are monophasic and do not suggest the existence of receptor populations with distinct affinities.
The present results show that full and partial agonist-induced inward currents have different kinetics with respect to both activation and desensitization of the inward current and recovery from desensitization. Recovery from desensitization induced by 5-HT is not monoexponential (Figure 5b ). In a previous study (Neijt et al., 1989) , we have corrected a delay in the recovery from 5-HT-induced desensitization, which was attributed to the delay in the superfusion system. However, the comparison of rapid (dopamine) and slow (mCPBG) recovery curves presented in Figure 5 clearly shows that the apparent delay observed with some agonists is not an artefact of the superfusion system. In the present experiments the rate of solution exchange has always been much faster than the rate of recovery from desensitization. Further, as previously shown for 5-HT (Neijt et al., 1989) and confirmed with mCPBG in the present experiments, the rate of recovery from desensitization depends only on the agonist used and not on its concentration. Together with the absence of an effect of the competitive antagonist TEA on the kinetics of recovery from desensitization this indicates that agonist reassociation cannot account for the sigmoid time course. The data on sigmoid recovery from full agonist-induced desensitization (Figure 5b ) exclude the possibility that the kinetics are determined by a single rate limiting dissociation step or conformational transition. Therefore, it has been assumed that recovery from desensitization involves multiple steps, which occur at similar rates (scheme [2] ). Dissociation of agonist molecules from multiple sites, multiple conformational transitions, or a combination of the two can all be described by the general sequential mechanism as presented in scheme [2] . The fitting of the data by Eqn. [3] with values of the exponent between 0.6 and 0.7 indicates that a minimum of one step is required for the recovery from partial agonist-induced desensitization, whereas recovery from full agonist-induced desensitization requires at least three steps, as indicated by exponential values of 2.4-2.6. The moderate potencies of the agonists suggest that the rate of dissociation is high as compared to the rate of recovery from desensitization (e.g., see Hammes & Schimmel, 1970) . The results of Figure 6d are consistent with the notion that agonist dissociation is not the rate limiting step in the recovery from desensitization, since the rate of recovery from tryptamine-induced desensitization when monitored with 5-HT is faster than when monitored with tryptamine. This indicates that some of the steps leading to the resting state are transitions between desensitized states of unoccupied 5-HT3 receptors. The experiments on recovery from cross-desensitization (Figure 6d ) confirm that the number of steps from the desensitized to the resting state depends on the agonist used to induce desensitization. Therefore, it is concluded that the partial agonists convert the receptor in a desensitized state that differs from the desensitized state induced by the full agonists. A reported delay in the recovery from desensitization of the ACh-induced ion current in BC3H1 cells (Dilger & Liu, 1992) indicates that a multistep mechanism might also apply to the recovery from desensitization of nACh receptors.
The results of Figure 6 demonstrate that, during the process of recovery from desensitization, the full agonists activate a larger fraction of the 5-HT3 receptors than the partial agonists. Since the concentrations of agonists used in the recovery experiments were sufficiently high to evoke maximum amplitude inward currents and because it has been excluded before that full and partial agonists act on specific subpopulations of 5-HT3 receptors (Figure 3) , the results suggest that full and partial agonists recognize distinct conformations of unoccupied, activatable 5-HT3 receptors. The principle of recognition of distinct, coexisting receptor conformations by different agonists has been referred to before as conformational selection (Kenakin, 1995) . Since the partial agonists recognize a subset of activatable receptors during recovery from desensitization, it is likely that a similar selection of resting, activatable 5-HT3 receptor conformations is responsible for the large difference in efficacy between full and partial agonists. The slow onset of inward curents induced by high concentrations of partial agonists (Figures la and 3 ) and the lower frequency of the dopamine-induced single channel events are consistent with the notion that the partial agonists act on resting receptor conformations that are less prevalent than those available for the full agonists. As the single channel parameters of full-and partial agonist-induced events are very similar (Figure 4) , the data provide no evidence for a role of conformational induction in agonist efficacy.
In conclusion, the results presented in this study provide evidence for a mechanism accounting for 5-HT3 receptor agonist efficacy in terms of conformational selection. Together with the hypothesis on the allosteric behaviour of ligand-gated ion channels (Jackson, 1995; Changeux & Edelstein, 1995) , this may provide a framework for understanding the dynamics of agonist-receptor interactions.
